Table 1 Demographic and clinical information of participants
PLWH N = 871 | Uninfected controls N = 4355 | |
|---|---|---|
Age in years, mean (SD) | 51 (11) | 52 (11) |
Female sex, n (%) | 121 (14%) | 643 (15%) |
European origin, n (%) | 635 (74%) | 3,992 (93%) |
Non-European origin, n (%) | 223 (26%) | 306 (7%) |
BMI kg/m2, mean (SD) | 25 (4) | 27 (4) |
Underweight, n (%) | 23 (2.7%) | 16 (0.4%) |
Normal, n (%), | 466 (54%) | 1645 (38%) |
Overweight, n (%) | 295 (34%) | 1917 (44%) |
Obese, n (%) | 83 (10%) | 766 (18%) |
WHR, mean (SD) | 0.9 (0.1) | 0.9 (0.1) |
Abdominal obese, n (%) | 532 (63%) | 2549 (59%) |
Former smoker, n (%) | 307 (35%) | 1582 (36%) |
Current smoker, n (%) | 246 (28%) | 553 (13%) |
Hypertension, n (%) | 364 (45%) | 1586 (37%) |
Diabetes, n (%) | 38 (4.5%) | 189 (4.4%) |
Triglycerides, mM mean (SD) | 2.1 (1.5) | 1.9 (1.3) |
HDL, mM, mean (SD) | 1.2 (0.5) | 1.3 (0.5) |
hsCRP, mg/L, mean (SD) | 2.7 (6) | 2 (5) |
Antilipidemics, n (%) | 108 (12%) | 421 (10%) |
Antihypertensives, n (%) | 138 (16%) | 610 (14%) |
Duration of cART, yr, median (IQR) | 11 (5, 7) | NA |
Undetectable, n (%) | 831 (95) | NA |
CD4 + nadir < 200cells/µL, n (%) | 346 (39) | NA |